{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:03:09Z","timestamp":1781625789585,"version":"3.54.5"},"reference-count":72,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104771","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T13:26:07Z","timestamp":1764595567000},"page":"104771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiotherapy for oral cavity cancers: 2025 update"],"prefix":"10.1016","volume":"29","author":[{"given":"Yasmine","family":"El Houat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lapeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Racadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Vieillevigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouchka","family":"Modesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Pointreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canrad.2025.104771_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/v15020451","article-title":"The prevalence of HPV in oral cavity squamous cell carcinoma","volume":"15","author":"Katirachi","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.canrad.2025.104771_bib0010","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/hed.27398","article-title":"Characteristics of oral squamous cell carcinoma focusing on cases unaffected by smoking and drinking: a multicenter retrospective study","volume":"45","author":"Harada","year":"2023","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.canrad.2025.104771_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.stomax.2011.04.004","article-title":"[Epidemiology of oral cavity cancers in France]","volume":"112","author":"Ligier","year":"2011","journal-title":"Rev Stomatol Chir Maxillofac"},{"issue":"1","key":"10.1016\/j.canrad.2025.104771_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000446117","article-title":"Global epidemiology of head and neck cancers: a continuing challenge","volume":"91","author":"Gupta","year":"2016","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.canrad.2025.104771_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","article-title":"Overview of the 8th edition TNM classification for head and neck cancer","volume":"18","author":"Huang","year":"2017","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104771_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.seminoncol.2019.07.002","article-title":"Modern radiotherapy for head and neck cancer","volume":"46","author":"Alterio","year":"2019","journal-title":"Semin Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104771_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.canrad.2017.12.005","article-title":"[Brachytherapy for head and neck cancers]","volume":"22","author":"Peiffert","year":"2018","journal-title":"Cancer Radiother"},{"issue":"Suppl 1","key":"10.1016\/j.canrad.2025.104771_bib0040","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/0973-1482.92218","article-title":"The role of intensity modulated radiotherapy in advanced oral cavity carcinoma","volume":"8","author":"Bhide","year":"2012","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"10.1016\/j.canrad.2025.104771_bib0045","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.ijrobp.2011.02.023","article-title":"Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy","volume":"81","author":"Sher","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104771_bib0050","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ijrobp.2010.04.031","article-title":"Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control","volume":"80","author":"Daly","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104771_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1748-717X-7-84","article-title":"Follow up after IMRT in oral cavity cancer: update","volume":"7","author":"Studer","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oraloncology.2017.07.002","article-title":"Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy","volume":"72","author":"Quinlan-Davidson","year":"2017","journal-title":"Oral Oncol"},{"issue":"Suppl.","key":"10.1016\/j.canrad.2025.104771_bib0065","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.canrad.2016.07.002","article-title":"Radiotherapy for oral cavity cancers","volume":"20","author":"Lapeyre","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104771_bib0070","series-title":"NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2","year":"2020"},{"key":"10.1016\/j.canrad.2025.104771_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coms.2018.08.002","article-title":"Oral cavity cancer","volume":"31","author":"Ettinger","year":"2019","journal-title":"Oral Maxillofac Surg Clin N Am"},{"key":"10.1016\/j.canrad.2025.104771_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.oraloncology.2016.02.012","article-title":"Positive frozen section margins predict local recurrence in R0-resected squamous cellcarcinoma of the head and neck","volume":"55","author":"Ettl","year":"2016","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0085","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/hed.21334","article-title":"Impact of positive frozen section microscopic tumor cut-through revised to negative on oral carcinoma control and survival rates","volume":"32","author":"Patel","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2025.104771_bib0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.18.01921","article-title":"Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline","volume":"37","author":"Koyfman","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104771_bib0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/s12885-020-07231-3","article-title":"A multicenter prospective phase II study of postoperative hypofractionated stereotacticbody radiotherapy (SBRT) in the treatment of early-stage oropharyngeal andoral cavity cancers with high risk margins: the STEREO POSTOP Gortec 2017-03 trial","volume":"20","author":"Biau","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2025.104771_bib0100","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2017.02.218","article-title":"Final report of a prospective randomized trial to evaluate the dose\u2013response relationship for postoperative radiation therapy and pathologic riskgroups in patients with head and neck cancer","volume":"98","author":"Rosenthal","year":"2017","journal-title":"Int J Radiat Oncol Biol"},{"key":"10.1016\/j.canrad.2025.104771_bib0105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2004.07.682","article-title":"Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter phase III study","volume":"61","author":"Sanguineti","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104771_bib0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(01)01690-X","article-title":"Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer","volume":"51","author":"Ang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104771_bib0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/jamaoto.2018.2716","article-title":"Association of treatment delays with survival for patients with head and neck cancer: a systematic review","volume":"145","author":"Graboyes","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.canrad.2025.104771_bib0120","first-page":"CD006386","article-title":"Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy","volume":"12","author":"Parmar","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"15_suppl.","key":"10.1016\/j.canrad.2025.104771_bib0125","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1200\/JCO.2020.38.15_suppl.6502","article-title":"Phase II\/III trial of postoperative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008)","volume":"38","author":"Kiyota","year":"2020","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.canrad.2025.104771_bib0130","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/cancers14153704","article-title":"Adding concomitant chemotherapy to postoperative radiotherapy in oral cavity carcinoma with minor risk factors: systematic review of the literature and meta-analysis","volume":"14","author":"Di Rito","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.canrad.2025.104771_bib0135","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1158\/1078-0432.CCR-21-3351","article-title":"Phase II clinical trial of neoadjuvant and adjuvant pembrolizumab in resectable local-regionally advanced head and neck squamous cell carcinoma","volume":"28","author":"Wise-Draper","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2025.104771_bib0140","doi-asserted-by":"crossref","first-page":"113560","DOI":"10.1016\/j.ejca.2024.113560","article-title":"Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer","volume":"200","author":"Noronha","year":"2024","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104771_bib0145","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/0194599817746909","article-title":"Primary surgery vs. radiotherapy for early stage oral cavity cancer","volume":"158","author":"Ellis","year":"2018","journal-title":"Otolaryngol Neck Surg"},{"key":"10.1016\/j.canrad.2025.104771_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104771_bib0160","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104771_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-yearsurvival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104771_bib0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.annonc.2022.10.006","article-title":"Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (Gortec 2015-01 PembroRad): a multicenter, randomized, phase II trial","volume":"34","author":"Tao","year":"2023","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104771_bib0175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"issue":"9538","key":"10.1016\/j.canrad.2025.104771_bib0180","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104771_bib0185","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1470-2045(10)70072-3","article-title":"Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of thehead and neck (IAEA-ACC study): a randomised, multicentre trial","volume":"11","author":"Overgaard","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2025.104771_bib0190","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1200\/JCO.2017.76.2591","article-title":"Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the Gortec 2007-02 phase III randomized trial","volume":"36","author":"Geoffrois","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0195","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","article-title":"Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group","volume":"31","author":"Blanchard","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0200","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104771_bib0205","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/hed.25739","article-title":"Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer","volume":"41","author":"Schilling","year":"2019","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.canrad.2025.104771_bib0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0215","doi-asserted-by":"crossref","first-page":"W17","DOI":"10.2214\/AJR.12.8960","article-title":"Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach","volume":"200","author":"Hoang","year":"2013","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.canrad.2025.104771_bib0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.oraloncology.2018.08.011","article-title":"Target delineation for postoperative treatment of head and neck cancer","volume":"86","author":"Evans","year":"2018","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104771_bib0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","article-title":"Proposal for the delineation of the nodal CTV in the node-positive and the postoperative neck","volume":"79","author":"Gr\u00e9goire","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.oraloncology.2018.10.034","article-title":"Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma","volume":"87","author":"Gr\u00e9goire","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104771_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.canrad.2005.03.005","article-title":"[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]","volume":"9","author":"Lapeyre","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104771_bib0250","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.canrad.2014.06.013","article-title":"[Delineation of the lymph nodes for head neck cancers]","volume":"18","author":"Lapeyre","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104771_bib0255","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2008.11.059","article-title":"Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer","volume":"75","author":"Salama","year":"2009","journal-title":"Int J Radiat Oncol Biol"},{"key":"10.1016\/j.canrad.2025.104771_bib0260","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","article-title":"Perineural invasion and perineural tumor spread in head and neck cancer","volume":"103","author":"Bakst","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104771_bib0265","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ijrobp.2015.12.002","article-title":"Patterns of recurrence in electively irradiated lymph node regions after definitive accelerated intensity modulated radiation therapy for head and neck squamous cell carcinoma","volume":"94","author":"van den Bosch","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104771_bib0270","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2025.104771_bib0275","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104771_bib0280","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","article-title":"Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck","volume":"84","author":"Cooper","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.canrad.2025.104771_bib0285","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2025.104771_bib0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2022.12.016","article-title":"Oral cavity adjuvant therapy (OCAT)\u00a0\u2013\u00a0a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr\/wk) versus concurrent CT-RT versus accelerated RT (6fr\/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity","volume":"181","author":"Laskar","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2025.104771_bib0295","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hed.23692","article-title":"Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy for oral cavity cancer","volume":"37","author":"Liu","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2025.104771_bib0300","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.canrad.2020.05.012","article-title":"[Impact of reconstructive or minimal invasive surgery on the assessment of current definitions of postoperative clinical target volume for head and neck cancers]","volume":"24","author":"Racadot","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104771_bib0305","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jcms.2015.02.021","article-title":"Marking of tumor resection borders for improved radiation planning facilitates reduction of radiation dose to free flap reconstruction in head and neck cancer surgery","volume":"43","author":"Bittermann","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"issue":"4","key":"10.1016\/j.canrad.2025.104771_bib0310","doi-asserted-by":"crossref","first-page":"e0266678","DOI":"10.1371\/journal.pone.0266678","article-title":"Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: feasibility of omitting lower-neck irradiation","volume":"17","author":"Ho","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.canrad.2025.104771_bib0315","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.08.018","article-title":"Revisiting the dose constraints for head and neck OARs in the current era of IMRT","volume":"86","author":"Brodin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0320","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.canrad.2020.07.004","article-title":"[Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited?]","volume":"24","author":"Lapeyre","year":"2020","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2025.104771_bib0325","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/hed.27336","article-title":"Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: a propensity score matched-pair analysis","volume":"45","author":"Ghosh Laskar","year":"2023","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.canrad.2025.104771_bib0330","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2018.01.004","article-title":"Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature","volume":"44","author":"Brands","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0335","doi-asserted-by":"crossref","first-page":"114064","DOI":"10.1016\/j.ejca.2024.114064","article-title":"N0 neck trial: does intensification of follow-up (ultrasound\u00a0+\u00a0physical examination) influence outcomes in early-stage oral cancer?","volume":"204","author":"Vaish","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2025.104771_bib0340","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canrad.2013.01.007","article-title":"[Brachytherapy for head and neck cancers]","volume":"17","author":"Lapeyre","year":"2013","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.canrad.2025.104771_bib0345","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"Gec-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104771_bib0350","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","article-title":"Gec-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update\u00a0\u2013\u00a0Improvement by cross sectional imaging-based treatment planning and stepping source technology","volume":"122","author":"Kov\u00e1cs","year":"2017","journal-title":"Radiother Oncol"},{"issue":"7\u20138","key":"10.1016\/j.canrad.2025.104771_bib0355","doi-asserted-by":"crossref","first-page":"104714","DOI":"10.1016\/j.canrad.2025.104714","article-title":"Best practice in brachytherapy: 2025 update","volume":"29","author":"Hannoun-L\u00e9vi","year":"2025","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104771_bib0360","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.canrad.2019.06.006","article-title":"[Post-treatment follow-up of head and neck cancer patients]","volume":"23","author":"Graff","year":"2019","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:18:41Z","timestamp":1768738721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":72,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001878"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104771","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for oral cavity cancers: 2025 update","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104771"}}